Navigation Links
NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference
Date:11/10/2008

SAN MATEO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York City on Tuesday, November 11, 2008. Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, will also be available to respond to questions during the breakout session immediately following the presentation.

Event: Rodman & Renshaw 10th Annual Healthcare Conference

Date: Tuesday, November 11, 2008

Time: 2:25 p.m. ET

Place: New York Palace Hotel, Holmes II (4th Floor)

The presentation will be webcast live and can be accessed by visiting the investor relations section of NeurogesX' website at http://www.neurogesx.com. The webcast will be archived for 15 days.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain condi
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NeurogesX Reports Third Quarter 2008 Results
2. NeurogesX to Report Third Quarter 2008 Financial Results
3. NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
4. NeurogesX Responds to EMEAs Day 120 Questions
5. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
6. NeurogesX Reports Second Quarter 2008 Results
7. NeurogesX to Report Second Quarter 2008 Financial Results
8. NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
9. NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
10. NeurogesX Reports First Quarter 2008 Results
11. NeurogesX to Report First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...f.,Nov.24/PRNewswire/--Twomoreprestigiousuniversit...inejobboardandcareerssiteforlifescienceprofessiona...embersofthejobboard,joining28othermajorlifescience...reercenter.com ,isonlyforpost-graduatesinthelifesc...esontheInternet,BioCareerCenteristheonlyonethatser...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs i...how consistent growth during the U.S. recession. H...trouble, and health systems are coming closer to h...f just administrators. , ...t continued growing in October despite the sheddin...
(Date:11/24/2009)...4/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Ch...ovedthe,investigationalnewdrugapplication(IND)fori...ormulationtotreatdiabetes.ThisIND,approvalallowsBi... Diabetesisadisordercharacteristicofhighbloodgluco...enresultinseveremicro-and,macro-vasculardiseases,l...
(Date:11/24/2009)... , TORONTO,Nov.24/PRNewswire-FirstCall/-Hamil....,aleadingproviderofadvancedlasersystemsandinstrum...s,todayreportedoperationalandfinancialresultsforth...lights,-Revenuewas$1.46millioncomparedwith$1.43mi...aredwith66.1percentinQ3,2008,-Netlossreducedto$148...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
... Micromet, Inc.,(Nasdaq: MITI ), a biopharmaceut...ies for the treatment of cancer, inflammation and ...stian Itin, President and Chief,Executive Officer ...cial,Group,s SIGnificant Investment Options Confer...he W Hotel in New York., Dr. Itin,s presentation ...
...r Group: CNN Expose Highlights Urgent Need for ...ARBARA, Calif., Feb. 29 CNN,s recent expose on,as...g reality that the,deadly carcinogen is virtually ...stos was used heavily in Navy ships and shipyards;...ding drywalls, flooring,roofing materials, and cem...
...endle (Nasdaq: KNDL ), a,leading, global full-ser...ed that Vice President and Chief Marketing Officer...nnual Raymond James,Institutional Investors Confer...ency Grand Cypress in Orlando, March 2-5, 2008. Ke...rch 5 at 1:40 p.m. Eastern Time., (Logo: http://...
Other Biology Technology:Micromet to Present at the Susquehanna Financial Group's SIGnificant Investment Options Conference on March 4, 2008 2Calling for a Cure 2Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference 2
(Date:11/23/2009)...ORONTO, November 23, 2009 - The time of day matter...to a new paper produced by a research team led by ...Scarborough,s vice-principal for research and coll...gy at the St. George campus. , Capitalizing on...oplar tree, the research team examined how poplar ...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
(Date:11/23/2009)...ERMORE, Calif. - By producing some of the highest ... surfaces, scientists have a deeper understanding ...his research may lead to a new treatment for kidne...ch appears in the Nov. 23 online edition of the jo...nces , explores how peptides interact with mineral...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3OMG Announces Special Event 3A Terminology Services Information Day 60441 1OMG Announces Special Event 3A Terminology Services Information Day 60441 2OMG Announces Special Event 3A Terminology Services Information Day 60441 3AARP Commends Legislature For Saving Critical Health Care Program 60438 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 2
...iberia,s Lake Baikal, the world,s largest and most...severe ecological disruption as a result of climat...ussian team in the May issue of BioScience. The la...nd was designated a World Heritage Site by UNESCO ...ora are found nowhere else. Perhaps the most alarm...
...LL, N.J., April 30 BIO-key International, Inc. (O...release first quarter 2009 financial results on We...conjunction with the release, BIO-key has schedule...over the Internet on Wednesday, May 6, 2009 at 10:...wscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , , ...
...pril 29, 2009 (BRONX, NY) Scientists at Albert E...have combined their revolutionary new drug-deliver...eat potentially deadly drug-resistant staph infect... the online version of the Journal of Investigati...ia cause the majority of superficial and invasive ...
Other Biology News:Climate change threatens Lake Baikal's unique biota 2BIO-key(R) Announces First Quarter Earnings Release and Conference Call Schedule 2New technology shows promise against resistant staph infections 2New technology shows promise against resistant staph infections 3
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
...d to coat the inner wall of tubing with DNA-coated...at enters target cells by helium discharge with th...upport cylinder, power cord, O-rings, tubing prep ... 0.1875 inch barb-to-male Luer-Lok fittings, nitro...
...s optimized blocking and wash solutions for microa...to-use wash solutions have been validated for use ...rays (Product Code S 9936). Microarray Hybridizat...ridization Wash Buffer I: 21L • Microarray P...
Biology Products: